Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent Covid-19 – a prospective multicentre cohort study

Philipp Kohler, Sabine Güsewell, Marco Seneghini, Thomas Egger, Onicio Leal, Angela Brucher, Eva Lemmenmeier, J. Carsten Möller, Philip Rieder, Markus Ruetti, Reto Stocker, Danielle Vuichard-Gysin, Benedikt Wiggli, Ulrike Besold, Stefan P. Kuster, Allison McGeer, Lorenz Risch, Andrée Friedl, Pietro Vernazza, Christian R. Kahlert
doi: https://doi.org/10.1101/2021.06.09.21258422

Article usage

Article usage: June 2021 to December 2024

AbstractFullPdf
Jun 202184212131
Jul 20212161229
Aug 2021214920
Sep 2021195241
Oct 2021148232
Nov 2021146222
Dec 202113109
Jan 202250116
Feb 20223027
Mar 20223113
Apr 20224224
May 202232311
Jun 20224927
Jul 20229302
Aug 202257213
Sep 20223518
Oct 20223715
Nov 20221905
Dec 20221938
Jan 202318111
Feb 20232429
Mar 20231801
Apr 20233128
May 20232016
Jun 20231642
Jul 20232028
Aug 202323105
Sep 20232146
Oct 20232438
Nov 2023391511
Dec 20232014
Jan 2024903
Feb 20241256
Mar 2024603
Apr 20241077
May 20241019
Jun 20241515
Jul 2024429
Aug 202418313
Sep 20242246
Oct 2024828
Nov 202418419
Dec 20241036
Back to top
Posted June 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent Covid-19 – a prospective multicentre cohort study
Philipp Kohler, Sabine Güsewell, Marco Seneghini, Thomas Egger, Onicio Leal, Angela Brucher, Eva Lemmenmeier, J. Carsten Möller, Philip Rieder, Markus Ruetti, Reto Stocker, Danielle Vuichard-Gysin, Benedikt Wiggli, Ulrike Besold, Stefan P. Kuster, Allison McGeer, Lorenz Risch, Andrée Friedl, Pietro Vernazza, Christian R. Kahlert
medRxiv 2021.06.09.21258422; doi: https://doi.org/10.1101/2021.06.09.21258422
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area